%0 Generic %A Polimanti, Afonso César %A Pereira, Lucas Abdo %A Carmine, Tainan Montecorado %A Fürst, Rafael Vilhena de Carvalho %A Bezerra, Alexandre Sacchetti %A Corrêa, João Antônio %D 2019 %T Influence of polidocanol ultrasound-guided foam sclerotherapy on quality of life in lower extremity chronic venous disease: initial results %U https://scielo.figshare.com/articles/dataset/Influence_of_polidocanol_ultrasound-guided_foam_sclerotherapy_on_quality_of_life_in_lower_extremity_chronic_venous_disease_initial_results/10073612 %R 10.6084/m9.figshare.10073612.v1 %2 https://scielo.figshare.com/ndownloader/files/18158135 %2 https://scielo.figshare.com/ndownloader/files/18158138 %K prospective studies %K quality of life %K sclerotherapy/adverse effects/methods %K surveys and questionnaires %K treatment outcome %K venous insufficiency/therapy %X

Abstract Chronic Venous Insufficiency (CVI) is not only detrimental to patients’ Quality of Life (QoL) but also places a considerable burden on public health resources. Ultrasound guided foam sclerotherapy (USFS) is a good treatment option, but its effect on patients’ QOL is still unclear. This article presents the results from the first 27 patients in a prospective, longitudinal, non-controlled study for evaluation of the clinical and QOL impact of USFS treatment for CEAP C4 to C6 grade CVI with contraindications for open surgery. Clinical symptoms were measured with the Venous Clinical Severity Score (VCSS) and QOL by the Assessment of Burden Chronic Disease - Venous questionnaire (ABC-V). We observed 22.2% reductions in VCSS (p<0.001) in the first week after the procedure, and a 37.8% reduction in ABC-V scores (p=0.03) over the first 3 months.

%I SciELO journals